![The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/e6efcdbc-0cc7-43ff-844a-0b7a07b15cb9/gr1_lrg.jpg)
The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus
![SciELO - Brazil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brazil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/3aad0880313aaaa98232afa144d67ec911e27a25.gif)
SciELO - Brazil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection
![Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41391-017-0024-7/MediaObjects/41391_2017_24_Fig1_HTML.jpg)
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases
![Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) | BMJ Open Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/12/4/e053118/F1.large.jpg)
Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) | BMJ Open
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)